Background: Wolf-Hirschhorn syndrome (WHS) is a contiguous gene syndrome that is typically caused by a deletion of the distal portion of the short arm of chromosome 4. However, there are few reports about the features of Chinese WHS patients. This study aimed to characterize the clinical and molecular cytogenetic features of Chinese WHS patients using the combination of multiplex ligation-dependent probe amplification (MLPA) and array comparative genomic hybridization (array CGH). Methods: Clinical information was collected from ten patients with WHS. Genomic DNA was extracted from the peripheral blood of the patients. The deletions were analyzed by MLPA and array CGH. Results: All patients exhibited the core clinical symptoms of WHS, including severe growth delay, a Greek warrior helmet facial appearance, differing degrees of intellectual disability, and epilepsy or electroencephalogram anomalies. The 4p deletions ranged from 2.62 Mb to 17.25 Mb in size and included LETM1, WHSC1, and FGFR3. Conclusions: The combined use of MLPA and array CGH is an effective and specific means to diagnose WHS and allows for the precise identification of the breakpoints and sizes of deletions. The deletion of genes in the WHS candidate region is closely correlated with the core WHS phenotype. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
IntroductIon
Wolf-Hirschhorn syndrome (WHS, OMIM 194190) is caused by the deletion of contiguous genes from the short arm of chromosome 4 and characterized by the Greek warrior helmet profile facial appearance, growth and development delays, intellectual disability, and seizures or electroencephalographic (EEG) anomalies. [1, 2] The WHS patients have been examined by novel technologies, such as array comparative genomic hybridization (array CGH) and multiplex ligation-dependent probe amplification (MLPA). [3, 4] Array CGH enables the detection of the precise sizes of deletions in the WHS candidate region (WHSCR) with greater accuracy compared with either fluorescence in situ hybridization (FISH) or conventional G-banded chromosome analysis alone. [5] In addition, MLPA allows for a more comprehensive determination of gene dosages with increased convenience and a relatively low cost compared with subtelomeric FISH analysis. [6] Moreover, MLPA can be used to detect micro-deletions that may not be identified by FISH.
Here, we reported the characteristics of ten Chinese patients with WHS, as determined by the combination of MLPA and array CGH.
Methods

Patients
Clinical information was collected for ten patients at the Genetics Clinic of the Peking University First Hospital between July 2008 and June 2014. Examining clinical manifestations and performing genetic analyses are necessary to diagnose WHS. Informed consent was obtained from all the patients' parents. The procedures followed in this investigation were approved by the Human Research Ethics Committee of the Peking University First Hospital.
Genetics
Conventional cytogenetic analysis Routine G-banding techniques at the 400 bands of resolution were performed. Genomic DNA was extracted from the peripheral blood of the patients using a QuickGene-610L system (FUJIFILM, Osaka, Japan). DNA purification was performed using a QIAamp DNA Kit (Qiagen, Germany), according to the manufacturer's protocol. Quantitative DNA analysis was performed using an ultraviolet NanoDrop 2000 spectrophotometer (Thermo Scientific, Wilmington, Delaware, USA).
Multiplex ligation-dependent probe amplification
MLPA analysis was performed to screen subtelomeric rearrangements using SALSA P070 and P036, and micro-deletion syndromes using SALSA P245 probemix (MRC-Holland, Amsterdam, the Netherlands). Both P070 and P036 contained one specific probe for 4p subtelomeric regions. The P245 contained special 2 probes for WHS. MLPA analysis was performed according to the manufacturer's instructions. The amplification products were identified and quantified by capillary electrophoresis using a 3130 XL genetic analyzer (Applied Biosystems, Foster City, USA). The fluorescence signal intensities of the PCR products were determined with Gene Marker l. 6 software (Softgenetics, State College, PA, USA).
Array comparative genomic hybridization
The kit of Agilent SurePrint G3 Human CGH Microarray 8×60K (Agilent Technologies, CA, USA) was used for genetic analysis according to the manufacturer's instructions. This microarray included 55,077 probes with a median probe space of 41 kb for intergenic genomic sequences. DNA hybridization was performed according to the standard procedures after the labeling of 500 ng of DNA from each of the patients with cyanine-5 and the labeling of control DNA (Promega, USA) with cyanine-3. The signals were captured according to the instructions of the Agilent SurePrint G3 CGH Microarray Kit. Microarray data were analyzed using Feature Extraction software and Workbench genomics software (Agilent Technologies, CA, USA). Probe alignments were performed using National Center for Biotechnology Information 37 (http://www.ncbi.nlm.nih.gov/), University of California, Santa Cruz hg19 build (http://genome.ucsc. edu/), and DECEPHER v8.8 (https://decipher.sanger.ac.uk/).
results
Clinical features of Chinese patients with Wolf-Hirschhorn syndrome
Detailed clinical data are presented in Table 1 . The patients were sorted by their distal chromosome 4p deletion sizes. Intrauterine growth restriction (IUGR) was detected in 5 patients. Hypotonia was detected in 9 patients, but was not observed in patient 1, who had smaller deletions. Postnatal growth delay occurred more frequently than IUGR. This severe growth delay was present in all patients. The Greek warrior helmet appearance was obvious in almost all the patients. Only two patients had cleft lip and palate. Patients 9 and 10 were excluded from the investigation of congenital heart defects due to insufficient information. A total of 5 patients displayed congenital heart defects, including atrial septal defects in three patients and pulmonary stenosis in two patients. The Gesell Developmental Schedule was administered to all patients to assess their levels of intellectual disability, except for patient 6 because of her age. All patients showed intellectual disability. The array CGH results revealed that among these 6 patients with disability, one patient with mild disability had small deletions (<3 Mb), 3 with moderate disability had moderate-sized deletions (3-14 Mb), and 2 with severe disability had large deletions (>14 Mb). Epilepsy or EEG anomalies were detected in 8 patients.
Motor developmental delay was detected in all patients, including difficulties in controlling the head and in sitting and walking. The feeding difficulty was found in 3 patients, renal abnormalities was found in 1 patient, and skeletal abnormalities was found in 1 patient.
Molecular and cytogenetic analyses
The genetic results, including MLPA and array CGH, are displayed in detail [Figures 1-3 and Table 2 ]. Deletions of the 4p terminus that were smaller than 5 Mb could not be recognized by karyotypic analysis. Deletions of 4p were detected in all patients with MLPA. The 4p16.3 deletions detected by array CGH ranged in size from 2.62 Mb to 17.25 Mb, with breakpoints at 0.07 Mb from the distal 4p telomere and at 17.32 Mb from the 4p telomere. LETM1 (OMIM 604407), WHSC1 (OMIM 602952), and FGFR3 (OMIM 134934) were deleted in all patients evaluated by array CGH.
dIscussIon
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Combined use of MLPA and array CGH was applied to evaluate WHS in our research. Routine G-banding techniques at the 400 bands of resolution were performed for karyotype. It was available and observable only when the deletion size was larger than 5 Mb. MLPA is more accurate to describe the karyotype due to its delicate probe spacing. A screening strategy is required for MLPA analysis of WHS, that is, using SALSA P070 and P036 for subtelomeric rearrangements first, and SALSA P245 or other further investigated kits second. [20] Array CGH is advanced in detecting the deletion genes and corresponding breakpoints in WHSCR, which is not only a complementary method for MLPA, but also helpful for precise medical therapy in the future. Therefore, the combined use of MLPA and array CGH facilitates the evaluation of WHS with greater accuracy than conventional cytogenetic methods.
The series reports of WHS are rare, especially for the Asian populations. Compared with the domestic reports of four patients with WHS, [13] the patients in the current study have a wide range of deletions, although ranging from less than 5 Mb to more than 15 Mb, but similar phenotypes. The main reason is that haploinsufficiency of the core candidate genes, WHSC1, LETM1, and FGFR3, is responsible for most of the WHS characteristics. [21, 22] All genes deleted in patients detected by array CGH were supplied [ Table 3 ]. This article aimed to help clinicians to recognize the features of Chinese WHS and diagnose it with appropriate molecular genetic methods through summing the corresponding phenotypes of different size of deletions. The results emphasized the relationship between genotype and phenotype which was consistent with the previous reports in Europe. [11] It also highlighted the importance of accurate diagnosis of WHS although the recurrence of WHS is low. [20] In conclusion, the combined use of array CGH and MLPA have increased the detection rate of submicroscopic chromosomal aberrations, and is an effective and specific means to diagnose WHS and allows for the precise identification of the breakpoints and sizes of deletions. This study presented detailed genotype-phenotype correlations in ten Chinese patients with WHS. More clinical and molecular cytogenetic data need to be collected for the study of genotype-phenotype correlations in Chinese patients.
